The Biden administration has invoked the Defense Production Act (“DPA”) to speed up the production of vaccines and increase the domestic production of COVID-19 tests, personal protective equipment (or “PPE”), and other essential supplies. Epstein Becker Green attorneys Neil Di Spirito, Constance Wilkinson, and Bonnie Odom discuss the administration’s reliance on the DPA as it continues to operationalize its pandemic response, and the challenges these actions are likely to present for medical product suppliers.
For more, listen to our previous episodes relating to vaccination and supply chain issues:
- COVID-19 Vaccines: The Ethical and Legal Challenges to Immunization
- Key Considerations for Reshoring U.S. Drug Manufacturing
About the Diagnosing Health Care Podcast
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Trouble listening to this podcast? Please contact Kelli Sakalousky at firstname.lastname@example.org and mention whether you were at home or working within a corporate network. We’d also love to hear your suggestions for future episode topics.
Spread the Word
Would your colleagues, professional network, or friends benefit from Diagnosing Health Care? Please share the edition each week on LinkedIn, Facebook, YouTube, Instagram, and Twitter, and your connections can subscribe for email notifications.